Roche Holding AG (ROG.SW)
Swiss - Swiss Delayed price. Currency in CHF
Add to watchlist
As of 09:59AM CEST. Market open.
| Previous close | 214.10 |
| Open | 213.60 |
| Bid | 214.10 x 0 |
| Ask | 214.20 x 0 |
| Day's range | 212.90 - 215.50 |
| 52-week range | 212.90 - 293.55 |
| Volume | |
| Avg. volume | 1,482,579 |
| Market cap | 172.915B |
| Beta (5Y monthly) | 0.15 |
| PE ratio (TTM) | 14.98 |
| EPS (TTM) | 14.30 |
| Earnings date | 25 Jul 2024 |
| Forward dividend & yield | 9.60 (4.48%) |
| Ex-dividend date | 14 Mar 2024 |
| 1y target est | 273.94 |
ZacksSarepta (SRPT) Q1 Earnings Beat Estimates, Revenues Up Y/Y
Sarepta (SRPT) reports better-than-expected Q1 earnings on the back of strong sales for recently-approved DMD gene therapy Elevidys.
- Thomson Reuters StreetEvents
Q1 2024 Sarepta Therapeutics Inc Earnings Call
Q1 2024 Sarepta Therapeutics Inc Earnings Call
ZacksRoche (RHHBY) Q1 Hit by Currency Headwinds, Lower COVID-19 Sales
Roche's (RHHBY) performance in first-quarter 2024 is pretty ho-hum as COVID-19-test sales continue to decline. The top line suffers due to the appreciation of the Swiss franc against most currencies.
© 2024 Yahoo. All rights reserved.